• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    An exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London, Friday, May 2, 2014.  The board of pharmaceutical company AstraZeneca on Friday rejected drug maker Pfizer's sweetened takeover offer. Pfizer earlier in the day said it is offering 50 pounds ($84) a share in cash and stock, a 7.3 increase on a previous bid. The offer values AstraZeneca at $106 billion. (AP Photo/Matt Dunham)
    Business

    AstraZeneca rejects sweetened Pfizer takeover bid

    DANICA KIRKALINDA A. JOHNSON -
    May 2, 2014 9:34 pm
    0
    AstraZeneca board rejects sweetened takeover offer from Pfizer
    Business

    AstraZeneca board rejects sweetened takeover offer from Pfizer

    Washington Examiner -
    May 2, 2014 9:56 am
    0
    West-Ward Pharmaceuticals settles with Texas, feds for $10M

    West-Ward Pharmaceuticals settles with Texas, feds for $10M

    Bryan Cohen -
    May 1, 2014 7:22 pm
    0
    Pfizer still pursuing AstraZeneca after 2nd rebuff
    Business

    Pfizer still pursuing AstraZeneca after 2nd rebuff

    DANICA KIRKALINDA A. JOHNSON -
    April 28, 2014 6:59 pm
    0
    AstraZeneca shares soar on Pfizer interest
    Business

    AstraZeneca shares soar on Pfizer interest

    Danica Kirka -
    April 28, 2014 11:16 am
    0
    FDA reviews psychiatric side effects of Chantix
    Business

    FDA reviews psychiatric side effects of Chantix

    Matthew Perrone -
    April 25, 2014 9:35 pm
    0
    Prestige to buy Insight Pharma for about $750M
    Business

    Prestige to buy Insight Pharma for about $750M

    Washington Examiner -
    April 25, 2014 12:01 pm
    0
    (Illustration by Karen Lomax/Examiner)
    Economy

    Big Ideas: On Big Tech, expensive drugs and haunted islands

    Joseph Lawler -
    April 25, 2014 4:00 am
    0
    Pfizer to help investors with dividend, buybacks
    Business

    Pfizer to help investors with dividend, buybacks

    The Associated Press -
    April 24, 2014 9:08 pm
    0
    J&J: Business doing well on new product approvals
    Business

    J&J: Business doing well on new product approvals

    Linda Johnson -
    April 24, 2014 8:27 pm
    0
    1...146147148...153Page 147 of 153
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter